Cause of rapid loss of vaccination protection

vaccination protection

Cause of rapid loss of vaccination protection in autoimmune diseases identified: People who are treated with TNF-α inhibitors for their autoimmune disease such as Crohn’s disease or rheumatoid arthritis lose their vaccination protection significantly earlier than average. The mechanism underlying the early decrease in antibody levels has now been eludicated by a scientific team from […]

Read More… from Cause of rapid loss of vaccination protection

Further illnesses still expected from SARS-CoV-2

SARS-CoV-2

SARS-CoV-2: Only neutralising antibodies allow conclusions to be drawn about protection against new infections: Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune responses due to previous infections and vaccinations, vaccinated and vulnerable individuals […]

Read More… from Further illnesses still expected from SARS-CoV-2

Finger-prick blood test identifies immunity to COVID-19

finger-prick

A finger-prick blood test can identify people most at risk of being reinfected with COVID-19. The simple test, developed by a small biotech firm based in Cardiff (ImmunoServ Ltd) in close collaboration with Cardiff University researchers, measures the presence of immune T cells that can recognise SARS-CoV-2. Over 300 volunteers were recruited from across the UK […]

Read More… from Finger-prick blood test identifies immunity to COVID-19

University will host world’s first Covid-19 vaccine booster trials

booster

The world’s first Covid-19 vaccine booster jab is to be administered at the University of Bradford’s cutting-edge Digital Health Enterprise Zone on June 1. The jabs are being tested as a possible precaution against variants of the coronavirus, with the trial lasting one year. The trial is being conducted by Bradford Teaching Hospitals NHS Foundation […]

Read More… from University will host world’s first Covid-19 vaccine booster trials